Search

everythinglearnresearchcommunity

for

Search:↓

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Alopecia areata severity and child's age greatly affect the quality of life for children and their parents.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Psoriasis patients are more likely to experience maladaptive daydreaming.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Lower vitamin D levels might be linked to more severe alopecia areata, but more research is needed to understand if vitamin D can help treat it.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.